Back

Real-world clinical burden of obstructive hypertrophic cardiomyopathy: a nationwide study in france

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Albert Alain Hagege

European Hospital Georges Pompidou, Paris (France)

6 More presentations in this session

Presentation thumbnail
Longitudinal burden of disease in hypertrophic cardiomyopathy: one-year follow-up of the AFFECT-HCM study
Miss R. Mangal (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Simplified versus complete selvester QRS scoring system for scar assessment in hypertrophic cardiomyopathy patients
Doctor N. Charoenpoonsiri (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Continuous ambulatory ECG monitoring of up to 14 days increases detection of high-risk ventricular tachyarrhythmias compared with the first 48 hours in hypertrophic cardiomyopathy
Doctor M. Maron (Burlington, US)
Abstract Slides Video
Presentation thumbnail
HCM in the modern era: low mortality and predominantly predictable sudden cardiac death under systematic risk stratification
Doctor E. Karvouni (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Mavacamten improves functional status in obstructive hypertrophic cardiomyopathy without increasing serious adverse events: a systematic review and meta-analysis
Doctor I. Figueroa Baez (San Juan, PR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term prognostic value of left ventricular outflow tract gradient in hypertrophic cardiomyopathy
28 August 2026
thumbnail
Congress Presentation
Clinical burden of obstructive and non-obstructive hypertrophic cardiomyopathy: insights from a nationwide study in France
19 May 2025
thumbnail
Congress Presentation
An italian real-world analysis of obstructive hypertrophic cardiomyopathy through a large administrative healthcare database
28 August 2023
thumbnail
Congress Presentation
Contemporary outcomes of patients with hypertrophic cardiomyopathy and atrial fibrillation: a nationwide matched cohort study
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources